of the Federal Food, Drug, and Cosmetic Act (FDCA).* Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York of the Federal Food, Drug, and Cosmetic Act (FDCA).*